Shuttle Pharmaceuticals Holdings Income Statement (2021-2026) | SHPH

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.04M
Operating items
Research & Development (Quarter) 0.19M0.44M0.30M0.08M0.67M-0.00M0.92M0.84M1.05M0.69M0.60M0.60M1.40M1.02M1.57M1.03M0.90M0.55M0.27M
Selling, General & Administrative (Quarter) 0.01M0.02M0.01M0.01M0.08M0.37M0.26M0.21M0.27M0.32M0.32M0.31M0.33M0.43M0.60M2.35M0.89M1.84M1.16M
Other Operating Expenses (Quarter) 0.05M0.53M0.33M0.26M0.33M0.16M0.37M0.42M0.29M0.27M0.46M0.57M1.32M0.33M0.78M0.54M0.48M1.10M0.79M
Operating Expenses (Quarter) 0.24M0.99M0.64M0.35M0.82M0.53M1.54M1.47M1.60M1.28M1.38M1.48M3.05M1.78M2.95M3.91M2.27M3.50M2.22M
Operating Income (Quarter) -0.24M-0.99M-0.64M-0.35M-0.82M-0.53M-1.54M-1.47M-1.60M-1.28M-1.38M-1.48M-3.05M-1.78M-2.95M-3.91M-2.27M-2.79M-2.22M
EBIT (Quarter) -0.24M-0.99M-0.64M-0.35M-0.82M-0.53M-1.54M-1.47M-1.60M-1.28M-1.38M-1.48M-3.05M-1.78M-2.95M-3.91M-2.27M-2.79M-2.22M
Non-operating items
Non Operating Investment Income (Quarter) 0.04M-0.03M0.01M0.05M-706.00-0.03M-0.04M
Interest & Investment Income (Quarter) 0.02M0.02M0.02M0.02M0.02M0.01M0.00M3.0081.00486.00523.00209.00
Other Non Operating Income (Quarter) 0.06M0.04M-0.06M0.11M-0.52M1.24M0.43M0.44M0.10M0.20M-0.14M0.29M0.22M0.00M0.01M0.00M0.33M0.08M
Non Operating Income (Quarter) 0.03M0.53M-0.04M-0.24M-0.18M-2.19M0.57M-0.72M-0.19M-0.36M-0.35M-0.55M-0.73M0.18M-0.10M0.20M-0.08M0.17M0.06M
Net income details
EBT (Quarter) -0.22M-0.46M-0.68M-0.37M-1.00M-2.72M-0.98M-2.00M-1.78M-2.20M-1.86M-1.90M-3.25M-1.71M-3.15M-4.22M-2.37M-2.79M-2.52M
Profit After Tax (Quarter) -0.22M-0.46M-0.68M-0.60M-1.00M-0.75M-0.98M-2.18M-1.79M-1.64M-1.73M-2.03M-3.78M-1.60M-3.05M-3.71M-2.35M-2.61M-2.15M
Income from Continuing Operations (Quarter) -0.22M-0.46M-0.68M-0.37M-1.00M-2.72M-0.98M-2.00M-1.78M-2.20M-1.86M-1.90M-3.25M-1.71M-3.15M-4.22M-2.37M-2.79M-2.52M
Consolidated Net Income (Quarter) -0.22M-0.46M-0.68M-0.37M-1.00M-2.72M-0.98M-2.00M-1.78M-2.20M-1.86M-1.90M-3.25M-1.71M-3.15M-4.22M-2.37M-2.79M-2.52M
Income towards Parent Company (Quarter) -0.22M-0.46M-0.68M-0.37M-1.00M-2.72M-0.98M-2.00M-1.78M-2.20M-1.86M-1.90M-3.25M-1.71M-3.15M-4.22M-2.37M-2.79M-2.52M
Preferred Dividend Payments (Quarter) 0.03M0.03M0.03M0.03M0.02M0.37M
Net Income towards Common Stockholders (Quarter) -0.24M-0.48M-0.71M-0.62M-1.02M-4.40M-0.98M-2.18M-1.79M-1.64M-1.86M-1.90M-3.25M-1.71M-3.15M-4.22M-2.37M-2.79M-2.52M
Additional items
EPS (Basic) (Quarter) -52.24-104.24-151.98-133.82-200.29-849.80-143.02-306.32-227.74-219.91-224.58-225.55-340.68-148.62-78.40-37.51-10.59-17.02-5.00
EPS (Diluted) (Quarter) -133.82-218.62-849.80-143.02-306.32-227.51-219.91-224.58-225.55-340.68-147.73-78.40-37.51-10.59-17.02-5.00
Shares Outstanding (Quarter) 0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.04M0.11M0.22M0.16M0.50M
Shares Outstanding (Diluted) (Quarter) 0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.04M0.11M0.22M0.16M0.50M
EBITDA (Quarter) -0.24M-0.99M-0.64M-0.35M-0.82M-0.53M-1.54M-1.47M-1.60M-1.28M-1.38M-1.48M-3.05M-1.78M-2.95M-3.91M-2.27M-2.79M-2.22M
Interest Expenses (Quarter) 0.01M0.02M0.01M0.02M0.02M0.60M0.55M0.62M-1.95M0.50M0.43M0.20M-0.07M0.20M0.31M0.10M0.30M